BTEE.L vs. IGLN.L
BTEE.L (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) and IGLN.L (iShares Physical Gold ETC) are both exchange-traded funds - BTEE.L is a Health & Biotech Equities fund tracking the NASDAQ Biotechnology TR USD, while IGLN.L is a Gold fund tracking the LBMA Gold Price. Both are passively managed. Over the past 5 years, BTEE.L returned 4.70%/yr vs 18.61%/yr for IGLN.L. At a 0.11 correlation, their price movements are largely independent. BTEE.L charges 0.35%/yr vs 0.25%/yr for IGLN.L.
Performance
BTEE.L vs. IGLN.L - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BTEE.L achieves a 4.58% return, which is significantly higher than IGLN.L's 3.70% return.
BTEE.L
- 1D
- 3.30%
- 1M
- 1.17%
- YTD
- 4.58%
- 6M
- 3.18%
- 1Y
- 41.45%
- 3Y*
- 13.12%
- 5Y*
- 4.70%
- 10Y*
- —
IGLN.L
- 1D
- 0.68%
- 1M
- -2.35%
- YTD
- 3.70%
- 6M
- 6.03%
- 1Y
- 32.37%
- 3Y*
- 31.55%
- 5Y*
- 18.61%
- 10Y*
- 13.42%
BTEE.L vs. IGLN.L - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
BTEE.L iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) | 4.58% | 32.82% | -1.69% | 5.84% | -11.88% | -0.57% | 27.55% | 25.56% | -14.84% |
IGLN.L iShares Physical Gold ETC | 3.70% | 64.92% | 26.14% | 13.44% | -0.09% | -4.03% | 24.16% | 18.28% | -3.09% |
Correlation
The correlation between BTEE.L and IGLN.L is 0.22, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.22 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.17 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.16 |
Correlation (All Time) Calculated using the full available price history since Mar 9, 2018 | 0.11 |
The correlation between BTEE.L and IGLN.L shifts across timeframes, from 0.11 (all time) to 0.22 (1 year), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BTEE.L vs. IGLN.L — Risk / Return Rank
BTEE.L
IGLN.L
BTEE.L vs. IGLN.L - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) (BTEE.L) and iShares Physical Gold ETC (IGLN.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| BTEE.L | IGLN.L | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.80 | ||
| Sortino ratioReturn per unit of downside risk | +1.27 | ||
| Omega ratioGain probability vs. loss probability | 1.35 | 1.25 | +0.10 |
| Calmar ratioReturn relative to maximum drawdown | 5.41 | 1.86 | +3.55 |
| Martin ratioReturn relative to average drawdown | 16.70 | 4.79 | +11.91 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| BTEE.L | IGLN.L | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.10 | 1.30 | +0.80 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.22 | 1.07 | -0.85 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.86 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.30 | 0.46 | -0.15 |
Drawdowns
BTEE.L vs. IGLN.L - Drawdown Comparison
The maximum BTEE.L drawdown since its inception was -38.29%, smaller than the maximum IGLN.L drawdown of -45.24%. Use the drawdown chart below to compare losses from any high point for BTEE.L and IGLN.L.
Loading charts...
Drawdown Indicators
| BTEE.L | IGLN.L | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -38.29% | -45.24% | +6.95% |
Max Drawdown (1Y)Largest decline over 1 year | -7.63% | -17.36% | +9.73% |
Max Drawdown (3Y)Largest decline over 3 years | -26.82% | -17.36% | -9.46% |
Max Drawdown (5Y)Largest decline over 5 years | -38.29% | -21.15% | -17.14% |
Max Drawdown (10Y)Largest decline over 10 years | — | -21.15% | — |
Current DrawdownCurrent decline from peak | -2.58% | -15.66% | +13.08% |
Average DrawdownAverage peak-to-trough decline | -13.56% | -19.80% | +6.24% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 2.47% | 6.74% | -4.27% |
Volatility
BTEE.L vs. IGLN.L - Volatility Comparison
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) (BTEE.L) has a higher volatility of 6.84% compared to iShares Physical Gold ETC (IGLN.L) at 6.36%. This indicates that BTEE.L's price experiences larger fluctuations and is considered to be riskier than IGLN.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BTEE.L | IGLN.L | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.84% | 6.36% | +0.48% |
Volatility (6M)Calculated over the trailing 6-month period | 15.33% | 21.73% | -6.40% |
Volatility (1Y)Calculated over the trailing 1-year period | 19.63% | 24.78% | -5.15% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 21.14% | 17.36% | +3.78% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 22.50% | 15.54% | +6.96% |
BTEE.L vs. IGLN.L - Expense Ratio Comparison
BTEE.L has a 0.35% expense ratio, which is higher than IGLN.L's 0.25% expense ratio.
Dividends
BTEE.L vs. IGLN.L - Dividend Comparison
BTEE.L's dividend yield for the trailing twelve months is around 0.36%, while IGLN.L has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
BTEE.L iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) | 0.36% | 0.37% | 0.46% | 0.39% | 0.44% | 0.25% | 0.17% | 0.14% | 0.07% |
IGLN.L iShares Physical Gold ETC | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
BTEE.L and IGLN.L have a correlation of 0.22, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, IGLN.L is cheaper at 0.25% per year. The better choice depends on whether you care most about return, fees, risk, or income.
IGLN.L is cheaper with a 0.25% expense ratio, compared with 0.35% for BTEE.L.
BTEE.L is categorized as Health & Biotech Equities, while IGLN.L is Gold. BTEE.L tracks NASDAQ Biotechnology TR USD, while IGLN.L tracks LBMA Gold Price. Their fees differ too: 0.35% for BTEE.L and 0.25% for IGLN.L.
Find the right allocation for BTEE.L and IGLN.L
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer